Cellular senescence and cancer: Focusing on traditional Chinese medicine and natural products
- PMID: 32881115
- PMCID: PMC7574878
- DOI: 10.1111/cpr.12894
Cellular senescence and cancer: Focusing on traditional Chinese medicine and natural products
Abstract
Cancer is the principal cause of death and a dominant public health problem which seriously threatening human life. Among various ways to treat cancer, traditional Chinese medicine (TCM) and natural products have outstanding anti-cancer effects with their unique advantages of high efficiency and minimal side effects. Cell senescence is a physiological process of cell growth stagnation triggered by stress, which is an important line of defence against tumour development. In recent years, active ingredients of TCM and natural products, as an interesting research hotspot, can induce cell senescence to suppress the occurrence and development of tumours, by inhibiting telomerase activity, triggering DNA damage, inducing SASP, and activating or inactivating oncogenes. In this paper, the recent research progress on the main compounds derived from TCM and natural products that play anti-cancer roles by inducing cell senescence is systematically reviewed, aiming to provide a reference for the clinical treatment of pro-senescent cancer.
Keywords: Traditional Chinese Medicine; active ingredients; cell senescence; tumour.
© 2020 The Authors. Cell Proliferation published by John Wiley & Sons Ltd.
Conflict of interest statement
No potential conflicts of interest are disclosed.
Figures
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7‐34. - PubMed
-
- Lou JS, Yao P, Tsim KWK. Cancer treatment by using traditional Chinese medicine: probing active compounds in anti‐multidrug resistance during drug therapy. Curr Med Chem. 2018;25(38):5128‐5141. - PubMed
-
- Xie Z, Wei Y, Xu J, Lei J, Yu J. Alkaloids from Piper nigrum synergistically enhanced the effect of paclitaxel against paclitaxel‐resistant cervical cancer cells through the downregulation of Mcl‐1. J Agric Food Chem. 2019;67(18):5159‐5168. - PubMed
-
- Zhang M, Zhang Y, Zhang L, Tian Q. Mushroom polysaccharide lentinan for treating different types of cancers: A review of 12 years clinical studies in China. Prog Mol Biol Transl. 2019;163:297‐328. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 2018ZX092011/Important Drug Development Fund, Ministry of Science and Technology of China
- 2018ZX09735-002/Important Drug Development Fund, Ministry of Science and Technology of China
- 81603253/National Natural Science Foundation of China
- 81873089/National Natural Science Foundation of China
- 81903933/National Natural Science Foundation of China
LinkOut - more resources
Full Text Sources
Medical
